Understanding tremors in kidney transplant recipients due to immunosuppression
Trajectory of Immunosuppression-Caused Tremor In Kidney Transplant Recipients
This study is trying to see how tremors affect kidney transplant patients taking certain medications over time to better understand and manage this side effect.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 60 (estimated) |
| Ages | 16 Years and up |
| Sex | All |
| Sponsor | University Medical Center Groningen Academic / other |
| Locations | 1 site (Groningen) |
| Trial ID | NCT06488651 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on kidney transplant recipients who are undergoing immunosuppressive therapy, particularly with calcineurin inhibitors like tacrolimus and cyclosporine. It aims to investigate the trajectory of tremors, a common side effect of these medications, to determine how the severity of tremors changes over time. By collecting data on both objective and subjective experiences of tremor, the study seeks to provide insights into the long-term effects of immunosuppression on patients. The findings could enhance understanding of tremor prevalence and its management in this population.
Who should consider this trial
Good fit: Ideal candidates for this study are patients aged 16 years and older who are scheduled to receive a kidney transplant.
Not a fit: Patients who are unable to comprehend the questionnaires and tests will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for tremors in kidney transplant recipients, enhancing their quality of life.
How similar studies have performed: While there have been studies on tremors related to immunosuppressive therapy, this specific investigation into the trajectory of tremor over time in kidney transplant recipients is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients ≥ 16 years old, who will receive a kidney transplant Exclusion Criteria: * patients who are unable to comprehend the questionnaires and tests
Where this trial is running
Groningen
- University Medical Center Groningen — Groningen, Netherlands (Recruiting)
Study contacts
- Study coordinator: Niels L Riemersma
- Email: n.l.riemersma@umcg.nl
- Phone: +31 50 361 6161
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.